Polypharmacy profiles and predictors among adults with autism spectrum disorders
Authors:
- Johanna K. LakeJLJohanna K. Lake
- Robert BaloghRBRobert Balogh
- Yona LunskyYLYona Lunsky
- 1 July 2012
- journal article
- Published by Elsevier in Research in Autism Spectrum Disorders
- Vol. 6 (3) , 1142-1149
Abstract
No abstract availableKeywords
This publication has 38 references indexed in Scilit:
- Intervention research to benefit people with autism: How old are the participants?Research in Autism Spectrum Disorders, 2012
- Medication and Parent Training in Children With Pervasive Developmental Disorders and Serious Behavior Problems: Results From a Randomized Clinical TrialJournal of the American Academy of Child & Adolescent Psychiatry, 2009
- A Longitudinal Investigation of Psychotropic and Non-Psychotropic Medication Use Among Adolescents and Adults with Autism Spectrum DisordersJournal of Autism and Developmental Disorders, 2009
- Systematic review of the effectiveness of pharmacological treatments for adolescents and adults with autism spectrum disorderAutism, 2007
- Medication Patterns in Patients with Autism: Temporal, Regional, and Demographic InfluencesJournal of Child and Adolescent Psychopharmacology, 2005
- Learning disability in the accident and emergency departmentAdvances in Psychiatric Treatment, 2005
- Prevalence and Patterns of Use of Psychoactive Medicines Among Individuals with Autism in the Autism Society of OhioJournal of Autism and Developmental Disorders, 2003
- Pharmacotherapy for Hyperactivity in Children with Autism and Other Pervasive Developmental DisordersJournal of Autism and Developmental Disorders, 2000
- Clomipramine in Adults with Pervasive Developmental Disorders: A Prospective Open-Label InvestigationJournal of Child and Adolescent Psychopharmacology, 1997
- Psychotropic and Anticonvulsant Drugs in Subjects with Autism: Prevalence and Patterns of UseJournal of the American Academy of Child & Adolescent Psychiatry, 1995